| Study of APD421 With and Without Ondansetron (NCT03583489) | Acacia Pharma Ltd | 2018-07-17 |
| QUILT-3.080: NANT Pancreatic Cancer Vaccine (NCT03586869) | ImmunityBio, Inc. | 2018-07-17 |
| Brain Stem Gliomas Treated With Adoptive Cellular Therapy During Focal Radiotherapy Recovery Alone or With Dose-intensified Temozolomide (Phase I) (NCT03396575) | University of Florida | 2018-07-17 |
| A Study to Evaluate How Aprocitentan is Safe and How it is Absorbed and Broken Down in the Body of Japanese and Caucasian Subjects (NCT03586570) | Idorsia Pharmaceuticals Ltd. | 2018-07-17 |
| Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma (NCT03275558) | Center Trials & Treatment | 2018-07-17 |
| PK Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel (NCT03467347) | International Partnership for Microbicides, Inc. | 2018-07-17 |
| IDH2 Inhibition Using Enasidenib as Maintenance Therapy for IDH2-mutant Myeloid Neoplasms Following Allogeneic Stem Cell Transplantation (NCT03515512) | Massachusetts General Hospital | 2018-07-17 |
| A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients (NCT03570957) | Tanabe Pharma Corporation | 2018-07-17 |
| Selinexor (KPT-330) Plus FLAG-Ida for the Treatment of Relapsing/Refractory AML (NCT03661515) | PETHEMA Foundation | 2018-07-17 |
| Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial (NCT02603328) | University of Chicago | 2018-07-17 |
| Effect of PBI-4050 on the Pharmacokinetics of Midazolam in Heathy Adult Subjects (NCT03637049) | Liminal BioSciences Ltd. | 2018-07-17 |
| Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas (NCT03283605) | Centre hospitalier de l'Université de Montréal (CHUM) | 2018-07-17 |
| Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population. (NCT04236960) | Walvax Biotechnology Co., Ltd. | 2018-07-17 |
| SP16 SERPIN-like Peptide Administration in Healthy Individuals (NCT03651089) | Serpin Pharma, LLC | 2018-07-16 |
| Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg (NCT03601910) | Chong Kun Dang Pharmaceutical | 2018-07-16 |
| A Dose-escalation Study of AND017 in Healthy Subjects (NCT04751539) | Kind Pharmaceuticals LLC | 2018-07-16 |
| Evaluation of the Pharmacokinetics of Prana P1 Capsules (NCT03744091) | The University of The West Indies | 2018-07-16 |
| Safety and Efficacy of Topical TolaSure on Skin Punch Biopsies in Healthy Participants (NCT03620175) | BioMendics, LLC | 2018-07-16 |
| Clinical Assessment of Oxiconazole Nitrate Solid Lipid Nanoparticles Loaded Gel (NCT03823040) | Minia University | 2018-07-16 |
| PET/MRI in the Diagnosis of Chronic Pain (NCT03556137) | Stanford University | 2018-07-16 |
| UVB-Induced MVP Release in Human Skin (NCT05734235) | Wright State University | 2018-07-16 |
| Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose of ZSP1603 in Healthy Adults (NCT03619616) | Guangdong Zhongsheng Pharmaceutical Co., Ltd. | 2018-07-16 |
| Benznidazole Absorption, Metabolism and Excretion Study (NCT03739541) | Exeltis France | 2018-07-16 |
| Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma (NCT03228537) | National Cancer Institute (NCI) | 2018-07-16 |
| Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene (NCT03602079) | Klus Pharma Inc. | 2018-07-16 |
| Assessment of Blood From Men Receiving Oral TU in Various Collection Tubes (NCT03973840) | Clarus Therapeutics, Inc. | 2018-07-15 |
| Cellular Immune Responses in Typhoid Fever Patients and Vaccinees (NCT03600025) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2018-07-15 |
| Phase I, Open-label, Non-randomized Study to Evaluate Safety of BC2059 (NCT03459469) | Iterion Therapeutics | 2018-07-15 |
| A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics (NCT03603132) | Jiangsu HengRui Medicine Co., Ltd. | 2018-07-14 |
| A Study to Investigate the Effect of JNJ-64565111 on Cardiac Repolarization (Corrected QT Interval) Compared With Placebo in Healthy Adults: a Thorough ECG Study Employing Placebo, JNJ-64565111, and a Positive Control (Moxifloxacin) (NCT03606057) | Janssen Research & Development, LLC | 2018-07-13 |
| STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain (NCT01904123) | M.D. Anderson Cancer Center | 2018-07-13 |
| A Study of Poziotinib in Combination With T-DM1 in HER2-Positive Breast Cancer (NCT03429101) | Spectrum Pharmaceuticals, Inc | 2018-07-13 |
| A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration (NCT03178149) | Astellas Institute for Regenerative Medicine | 2018-07-13 |
| A Study of LY3322207 in Healthy Participants and in Participants With Hypertension (High Blood Pressure) (NCT03590860) | Eli Lilly and Company | 2018-07-13 |
| Study Evaluating Betrixaban in Pediatric Participants (NCT03346083) | Alexion Pharmaceuticals, Inc. | 2018-07-13 |
| A Study of JNJ-64619178, an Inhibitor of PRMT5 in Participants With Advanced Solid Tumors, NHL, and Lower Risk MDS (NCT03573310) | Janssen Research & Development, LLC | 2018-07-13 |
| A Study With ABBV-155 Alone and in Combination With Taxane Therapy in Adults With Relapsed and/or Refractory Solid Tumors (NCT03595059) | AbbVie | 2018-07-13 |
| A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer (NCT03532880) | Memorial Sloan Kettering Cancer Center | 2018-07-12 |
| Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS (NCT03534323) | Dana-Farber Cancer Institute | 2018-07-12 |
| Study of Resiniferatoxin for Knee Pain in Moderate to Severe Osteoarthritis (NCT03542838) | Sorrento Therapeutics, Inc. | 2018-07-12 |
| Fasted Bioequivalence Study of Clopidogrel Film-coated Tablets, 75 mg in 48 Healthy, Adult Male and Female Subjects. (NCT05125549) | Joint Stock Company "Farmak" | 2018-07-12 |
| Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders (NCT03732248) | Medical University of South Carolina | 2018-07-12 |
| Clinical Trial on Personalized Neoantigen Vaccine for Pancreatic Tumor (NCT03558945) | Anda Biopharmaceutical Development (Shenzhen) Co., Ltd. | 2018-07-12 |
| Lenvatinib and Eribulin in Advanced Soft Tissue Sarcoma (NCT03526679) | National Taiwan University Hospital | 2018-07-12 |
| A Study of Effects of Selpercatinib (LY3527723) on Midazolam in Healthy Participants (NCT05338476) | Eli Lilly and Company | 2018-07-12 |
| Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer (NCT03552471) | Ohio State University Comprehensive Cancer Center | 2018-07-12 |
| Pro-arrhythmic Potential of GSK3039294 in Healthy Subjects (NCT03567499) | GlaxoSmithKline | 2018-07-12 |
| Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients (NCT03465345) | Medical University of South Carolina | 2018-07-11 |
| A Study of HQP1351 in Patients With GIST or Other Solid Tumors (NCT03594422) | Ascentage Pharma Group Inc. | 2018-07-11 |
| First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis (NCT03559166) | Blade Therapeutics | 2018-07-11 |
| A Study to Examine the Effect of Tesofensine and Metoprolol on the 24-hour Mean Heart Rate (NCT03488719) | Saniona | 2018-07-11 |
| A Study to Investigate the Whole Body Distribution and Radiation Dosimetry of the Positron Emission Tomography Ligand Fluoride-18 (18F)-JNJ-64326067 in Healthy Participants (NCT03581916) | Janssen Research & Development, LLC | 2018-07-11 |
| This Study in Healthy Men Tests How Different Doses of BI 1265162 Are Taken up in the Body and How Well They Are Tolerated. (NCT03576144) | Boehringer Ingelheim | 2018-07-11 |
| Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis (NCT03618784) | Kang Stem Biotech Co., Ltd. | 2018-07-11 |
| Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients (NCT03438773) | California Institute of Renal Research | 2018-07-11 |
| Adalimumab Microneedles in Healthy Volunteers (NCT03607903) | Centre for Human Drug Research, Netherlands | 2018-07-11 |
| Drug-drug Interaction Study of Ozanimod With Pseudoephedrine to Evaluate the Effect on Blood Pressure and Heart Rate (NCT03644576) | Celgene | 2018-07-11 |
| Study of MK-4830 as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4830-001) (NCT03564691) | Merck Sharp & Dohme LLC | 2018-07-11 |
| Study of ITI-214 in Healthy Volunteers to Determine CNS Engagement (NCT03489772) | Intra-Cellular Therapies, Inc. | 2018-07-10 |
| Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors (NCT03583086) | Vanderbilt-Ingram Cancer Center | 2018-07-10 |
| IA Carboplatin + Radiotherapy in Relapsing GBM (NCT03672721) | Université de Sherbrooke | 2018-07-10 |
| Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT (NCT03435952) | M.D. Anderson Cancer Center | 2018-07-10 |
| A Phase I Clinical Study Trial of Felbinac Trometamol Injection in China (NCT03617510) | Shijiazhuang Yiling Pharmaceutical Co. Ltd | 2018-07-10 |
| Controlled Human Infection for Vaccination Against Streptococcus Pyogenes (NCT03361163) | Andrew Steer | 2018-07-10 |
| A Long-Term Follow-Up Study of Haemophilia B Patients Who Have Undergone Gene Therapy (NCT03641703) | Spur Therapeutics | 2018-07-10 |
| PK/PD Biosimilarity Study of Gan & Lee Insulin Glargine Injection vs.US & EU Lantus® in Type 1 Diabetes Mellitus Patients (NCT04236895) | Gan and Lee Pharmaceuticals, USA | 2018-07-10 |
| Randomized, Double-Blind, Placebo-Controlled, Safety and Tolerability Study of ITI-214 in Patients With Heart Failure (NCT03387215) | Intra-Cellular Therapies, Inc. | 2018-07-10 |
| A Study to Investigate the Effect of Itraconazole on the PK of Multiple Doses of Balovaptan in Healthy Volunteers (NCT03579719) | Hoffmann-La Roche | 2018-07-10 |
| Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects (NCT03570346) | Tianjin Hemay Bio-Tech Co., Ltd | 2018-07-10 |
| TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma (NCT03506802) | Jonsson Comprehensive Cancer Center | 2018-07-10 |
| Pharmacokinetic Equivalence and Safety Study of RPH-001 and Avastin® (NCT03659305) | R-Pharm | 2018-07-10 |
| First-in-human Study of Oral TP-0184 in Patients With Advanced Solid Tumors (NCT03429218) | Sumitomo Pharma America, Inc. | 2018-07-10 |
| Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer (NCT03566485) | Vanderbilt-Ingram Cancer Center | 2018-07-10 |
| Phase I Study to Evaluate a Human Monoclonal Antibody (MAb) 10E8VLS Administered Alone or Concurrently With MAb VRC07-523LS Via Subcutaneous Injection in Healthy Adults (NCT03565315) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-07-10 |
| Magnesium Sulphate Versus Lidocaine for Control of Emergence Hypertension (NCT03566329) | Ahmed Mohamed ELbadawy | 2018-07-10 |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors (NCT03517488) | Xencor, Inc. | 2018-07-10 |
| AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Non Hodgkin Lymphoma (NCT03434769) | Benjamin Tomlinson | 2018-07-09 |
| Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer (NCT03107780) | National Cancer Institute (NCI) | 2018-07-09 |
| Comparative Bioavailability of Risperidone (NCT03527186) | Rovi Pharmaceuticals Laboratories | 2018-07-09 |
| Peptide Receptor Radionuclide Therapy Administered to Participants With Meningioma With 67Cu-SARTATE™ (NCT03936426) | Clarity Pharmaceuticals Ltd | 2018-07-09 |
| UV1 Vaccine With Pembrolizumab for Patients With Unresectable or Metastatic Melanoma (NCT03538314) | Ultimovacs ASA | 2018-07-09 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of IONIS FXI-LRx in up to 84 Healthy Volunteers (NCT03582462) | Ionis Pharmaceuticals, Inc. | 2018-07-09 |
| A Phase 1a/1b Study of CB4211 in Healthy Non-obese Subjects and Subjects With Nonalcoholic Fatty Liver Disease (NCT03998514) | CohBar, Inc. | 2018-07-09 |
| BLU-5937: First-in-Human, Single and Multiple Doses Escalation, Safety, Tolerability, Pharmacokinetics and Food Effect (NCT03638180) | Bellus Health Inc. - a GSK company | 2018-07-09 |
| Evaluation of Bioavailability and Metabolism of Diet Phenolic Compounds (NCT03614520) | Parc de Salut Mar | 2018-07-09 |
| Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease (NCT03158896) | University of Kansas Medical Center | 2018-07-09 |
| Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of SH229 in Patients With HCV Infection (NCT03588923) | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 2018-07-07 |
| A Pilot Study of Additional Chinese Formula for Concurrent Chemoradiotherapy in Oral Cavity Cancer Patients (NCT05590650) | China Medical University Hospital | 2018-07-07 |
| A Study to Evaluate the Safety and Immunogenicity for Regimen Selection of Ad26.RSV.preF and/or RSV preF Protein Combinations Followed by Expanded Safety Evaluation in Adults Aged 60 Years and Older (NCT03502707) | Janssen Vaccines & Prevention B.V. | 2018-07-06 |
| Population Pharmacokinetic-pharmacodynamic (PK-PD) Study of 9 Broad-Spectrum Anti-infective Agents in the Cerebro Spinal Fluid (CSF) of Brain Injured Patients With an External Ventricular Drainage (EVD). (NCT03481569) | Poitiers University Hospital | 2018-07-06 |
| Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome (NCT03494569) | City of Hope Medical Center | 2018-07-06 |
| Safety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D4Δ30-713 in Flavivirus-naïve Adults (NCT03611946) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-07-06 |
| Study of CDX-3379, a Human Monoclonal Antibody Targeting ERBB3, in Combination With the MEK Inhibitor, Trametinib, in Patients With Advanced Stage NRAS Mutant and BRAF/NRAS Wildtype (WT) Melanoma (NCT03580382) | NYU Langone Health | 2018-07-06 |
| E GFR TKI and EGF-P TI C Ombination in EGFR mutA nt NSCL C (NCT03623750) | Instituto Oncológico Dr Rosell | 2018-07-06 |
| Safety, Tolerability, and Pharmacokinetics of Oral BT-11 in Healthy Adult Male and Female Volunteers (NCT03860571) | NImmune Biopharma | 2018-07-06 |
| Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease. Extension to HP-CD-CL-2002 Clinical Study (NCT03775538) | Herantis Pharma Plc. | 2018-07-05 |
| Intravenous Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) (NCT03392909) | University of Southern California | 2018-07-05 |
| Study to Evaluate the Safety, Tolerate, Pharmacokinetics and Preliminary Efficacy of CYH33 (NCT03544905) | Haihe Biopharma Co., Ltd. | 2018-07-05 |
| Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy (NCT03253744) | National Cancer Institute (NCI) | 2018-07-05 |
| A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours (NCT03468426) | Boehringer Ingelheim | 2018-07-05 |